Guidance

Pregabalin and gabapentin: advice for prescribers on the risk of misuse

Advice for prescribers on the risk of misuse of pregabalin and gabapentin, and suggestions for a balanced and rational use of these medicines.

• From: Public Health England and NHS England
• Published: 11 December 2014

Documents

Advice for prescribers on the risk of the misuse of pregabalin and gabapentin

Ref: PHE publications gateway number: 2014586; NHS England publications gateway number 02387

PDF, 157 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

PHE and NHS England have published an expert group’s advice for prescribers on the risk of misuse of pregabalin and gabapentin, and suggestions for a balanced and rational use of these medicines. The advice will be of use to local healthcare providers and clinicians.

Published 11 December 2014